VIB
Investments
17Portfolio Exits
4Partners & Customers
10About VIB
VIB provides basic research in life sciences. VIB's technology transfer activities translate research results into new, economic ventures, which, in time, lead to new products that can be used in medicine, agriculture, and other applications. VIB also engages actively in the public debate on biotechnology by developing and disseminating a wide range of science-based information about all aspects of biotechnology.
VIB Headquarter Location
Rijvisschestraat 120
Ghent, 9052,
Belgium
+32 9 244 66 11
VIB Web Traffic
VIB Rank
VIB Investments
17 Investments
VIB has made 17 investments. Their latest investment was in Muna Therapeutics as part of their Series A on July 7, 2021.
VIB Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
7/9/2021 | Series A | Muna Therapeutics | $73M | Yes | 12 | |
4/8/2021 | Series A | Protealis | $7.12M | Yes | 2 | |
3/16/2021 | Series A - II | ExeVir Bio | $22.65M | No | 1 | |
11/30/2020 | Series B | |||||
7/28/2020 | Series A |
Date | 7/9/2021 | 4/8/2021 | 3/16/2021 | 11/30/2020 | 7/28/2020 |
|---|---|---|---|---|---|
Round | Series A | Series A | Series A - II | Series B | Series A |
Company | Muna Therapeutics | Protealis | ExeVir Bio | ||
Amount | $73M | $7.12M | $22.65M | ||
New? | Yes | Yes | No | ||
Co-Investors | |||||
Sources | 12 | 2 | 1 |
VIB Portfolio Exits
4 Portfolio Exits
VIB has 4 portfolio exits. Their latest portfolio exit was Biotalys on July 01, 2021.
VIB Partners & Customers
10 Partners and customers
VIB has 10 strategic partners and customers. VIB recently partnered with Hedera-22 on January 1, 2022.
Date | Type | Business Partner | Country | News Snippet | Sources |
|---|---|---|---|---|---|
1/10/2022 | Partner | Belgium | |||
12/22/2021 | Partner | Netherlands | SkylineDx And VIB Enter A Strategic Partnership In Molecular Diagnostics ROTTERDAM , Netherlands and SAN DIEGO and GHENT , Belgium , Dec. 22 , 2021 / PRNewswire / -- Today , SkylineDx announced a 3-year strategic partnership with life sciences institute VIB for the evaluation and initiation of collaborative projects focused on molecular diagnostics . | 3 | |
12/22/2021 | Partner | Netherlands | SkylineDx and VIB Enter a Strategic Partnership in Molecular Diagnostics - CMOCRO ROTTERDAM , Netherlands and SAN DIEGO and GHENT , Belgium , Dec. 22 , 2021 / PRNewswire / -- Today , SkylineDx announced a 3-year strategic partnership with life sciences institute VIB for the evaluation and initiation of collaborative projects focused on molecular diagnostics . | 1 | |
12/22/2021 | Partner | ||||
5/6/2021 | Licensee |
Date | 1/10/2022 | 12/22/2021 | 12/22/2021 | 12/22/2021 | 5/6/2021 |
|---|---|---|---|---|---|
Type | Partner | Partner | Partner | Partner | Licensee |
Business Partner | |||||
Country | Belgium | Netherlands | Netherlands | ||
News Snippet | SkylineDx And VIB Enter A Strategic Partnership In Molecular Diagnostics ROTTERDAM , Netherlands and SAN DIEGO and GHENT , Belgium , Dec. 22 , 2021 / PRNewswire / -- Today , SkylineDx announced a 3-year strategic partnership with life sciences institute VIB for the evaluation and initiation of collaborative projects focused on molecular diagnostics . | SkylineDx and VIB Enter a Strategic Partnership in Molecular Diagnostics - CMOCRO ROTTERDAM , Netherlands and SAN DIEGO and GHENT , Belgium , Dec. 22 , 2021 / PRNewswire / -- Today , SkylineDx announced a 3-year strategic partnership with life sciences institute VIB for the evaluation and initiation of collaborative projects focused on molecular diagnostics . | |||
Sources | 3 | 1 |
VIB Team
5 Team Members
VIB has 5 team members, including current Chief Financial Officer, Rik Audenaert.
Name | Work History | Title | Status |
|---|---|---|---|
Rik Audenaert | International Paper, and PwC | Chief Financial Officer | Current |
Wim Goemaere | Bone Therapeutics, deVGen, and BP | Chief Operating Officer | Current |
Johan Cardoen | Managing Director | Former | |
Rudy Dekeyser | Managing Director | Former | |
beth coulter | Owner | Former |
Name | Rik Audenaert | Wim Goemaere | Johan Cardoen | Rudy Dekeyser | beth coulter |
|---|---|---|---|---|---|
Work History | International Paper, and PwC | Bone Therapeutics, deVGen, and BP | |||
Title | Chief Financial Officer | Chief Operating Officer | Managing Director | Managing Director | Owner |
Status | Current | Current | Former | Former | Former |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.